⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
Insurance AI Leader mea Platform Targets Industry Combined Ratios and Margins With a $50 Million Growth Equity Raise From SEP
businesswire.com
AXS
CNA
MRK
VRSK
Insurance AI Leader mea Platform Targets Industry Combined Ratios and Margins With a $50 Million Growth Equity Raise From SEP
businesswire.com
AXS
CNA
MRK
ACN
DXC
NOW
VERI
Poxel Reports its 2025 Revenue and Provides an Update on its Financial Position
businesswire.com
MRK
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
FATE
INDP
AMGN
NKTR
IBIO
TAK
SNY
INMB
CLMT
VERX
GTBP
BHVN
CHRS
GSK
BMY
MRK
ABBV
AZN
GILD
LLY
KYMR
REGN
SPRY
Veterinary Pharmaceuticals Market worth $39.37 billion by 2031 | MarketsandMarkets™
prnewswire.com
ZTS
MRK
ELAN
Immune Checkpoint Inhibitor Therapy May Reduce Asthma Exacerbations
prnewswire.com
MRK
BMY
Sphingolipids Market Forecast 2025-2035: Global Value to Reach USD 1,145.6 Million by 2035 at 5.1% CAGR
prnewswire.com
MRK
CROX
Animal Parasiticides Market worth $17.50 billion by 2031 | MarketsandMarkets™
prnewswire.com
ZTS
MRK
ELAN
PAHC
Global Conjugate Vaccine Market to Reach USD 21.77 Billion by 2030 | MarketsandMarkets™
globenewswire.com
PFE
MRK